July 22, 2016 Press Release/Press Release and Statements
TGN is exploring a potential relationship with the Moffitt Cancer Center to develop TGN 's FiSS4D Tumorous culture technology platform, anti-cancer drug discovery and development, and personalized cancer treatments.
June 16, 2016 Press Release/Press Release and Statements
TGN partnered with Funakoshi Co. LTD, a distributor of research reagents and instruments for researchers to begin selling and distributing its Fiber-inspired Smart Scaffold (FiSSTM)-based Tumorous culture products in Japan.
July 12, 2015 Featured/USF Oracle/In the News
The Oracle, a USF student-run newspaper reports on TGN's Tumor-on-a-dish product.
August 13. 2015 Press Release/Press Release and Statements
TGN welcomes Dr. Chandresh Saraiya, formerly chairman and CEO of privately held clinical research startup, Nanotech Diagnostics and Therapeutics Inc (NDT) in Tampa, Florida, as TGN's new president.
September 21, 2015 Featured/In the News
TGN wins Tampa Bay Technology Forum's 2015 Innovative Project of The Year.
June 18, 2015 Press Release/Featured/In the News
The Florida Institute for the Commercialization of Public Research, a non-profit organization that works with universities to leverage a $2B+ research base, announced its finalization of a funding agreement with TGN.
October 14, 2014 Featured/In the News
TGN co-founder Dr. Subhra Mohapatra received the USF Excellent in Innovation Award recognizing the highest levels of technological innovation and entrepreneurial success.
September 15, 2014 Featured/In the News
TGN co-founder Dr. Shyam Mohaptra is inducted into the Florida Inventors Hall of Fame in Tampa, FL. Dr. Mohapatra was recognized for his pioneering innovations in the field of applied biomedical nanotechnology.
Have any questions about Transgenex Nanobiotech?
Use this form to get in touch.